Leg Twitching with Pyridostigmine (Mestinon)
Yes, leg twitching is a common side effect of pyridostigmine (Mestinon), particularly at doses of 500mg, due to its nicotinic effects causing involuntary skeletal muscle contractions. 1, 2
Mechanism of Action and Side Effects
Pyridostigmine is an acetylcholinesterase inhibitor that prevents the breakdown of acetylcholine, leading to:
- Increased acetylcholine concentration at neuromuscular junctions
- Prolonged activation of both muscarinic and nicotinic receptors 1
The side effects of pyridostigmine fall into two main categories:
Nicotinic effects (relevant to leg twitching):
- Muscle fasciculations (twitching)
- Muscle cramps
- Weakness 2
Muscarinic effects:
- Increased secretions (salivation, bronchial secretions)
- GI symptoms (nausea, vomiting, diarrhea, abdominal cramps)
- Increased sweating (diaphoresis)
- Miosis 2
Prevalence and Severity
- Approximately 91% of patients experience some muscle twitching at doses of 150mg or higher 1
- At 500mg, which is a very high dose, muscle twitching would be expected to be more pronounced
- The FDA drug label specifically lists muscle fasciculation as a common nicotinic side effect 2
Clinical Significance
The constant activation of nicotinic receptors can generate involuntary skeletal muscle contractions (twitching), which may progress to complete depolarization-like block with higher doses 3. This represents the unopposed actions of acetylcholine on nicotinic receptors at the neuromuscular junction.
Management of Muscle Twitching
If leg twitching becomes problematic:
- Dose reduction may be considered if clinically appropriate 1
- Spreading doses more evenly throughout the day may help alleviate symptoms 1
- Monitoring for progression to more severe symptoms is essential 1
- For severe nicotinic side effects, atropine can counteract some effects, but this approach carries its own risks 2
Important Considerations
- Muscle twitching alone is generally not dangerous but can be uncomfortable
- If twitching is accompanied by severe weakness, respiratory difficulty, or other concerning symptoms, this could indicate cholinergic crisis requiring immediate medical attention
- The 500mg dose is significantly higher than typical therapeutic doses used for myasthenia gravis (typically 30-120mg three to four times daily) 1
Pyridostigmine at high doses like 500mg can impair neuromuscular function even beyond the period of active drug administration, as demonstrated in research studies 4, so monitoring for persistent effects is warranted.